Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
VCs Invest $23M In Roche Holding Spinout Afferent Pharmaceuticals
News | 12. 16. 2009
Afferent Pharmaceuticals
Venture firms are investing $23 million to spin out a start-up from Roche Holding Ltd. that plans to attack chronic pain in a new way.
